![](https://webarchive.library.unt.edu/eot2008/20090201180718im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090201180718im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090201180718im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090201180718im_/http://www.cancer.gov/images/spacer.gif) |
CCR Grand Rounds |
![](https://webarchive.library.unt.edu/eot2008/20090201180718im_/http://www.cancer.gov/images/spacer.gif) |
October 26: Dr. Michael B. Sporn, Professor of Pharmacology, Dartmouth Medical School, "Chemoprevention
of Cancer: New Approaches, New Agents, New Mechanisms"
November 2: Dr. Andrei Kozlov, Director, St. Petersburg Biomedical Center, St. Petersburg, Russia, "Tumor Markers and Evolution"
CCR Grand Rounds are held 8:30 to 9:30 a.m. at the NIH campus in Bethesda, Md., in the Clinical Center's Lipsett Auditorium.
|
|
Report Shows Exercise is Key for Cancer Survivors
Exercise programs during and after cancer treatment can improve functional
capacity and cardiopulmonary fitness, reduce symptoms of fatigue, and improve a
patient's quality of life, according to a new report released in August by the
Agency for Healthcare Research and Quality (AHRQ). The report, funded by NCI,
also shows that exercise programs can reduce cancer patients' symptoms of
anxiety and depression during treatment.
The study, led by researchers at the
University of Minnesota's Evidence-Based Practice Center, looked at studies
published between 1996 and 2003 - specifically, studies that tested the effect of
physical activity interventions, alone or combined with diet modification or
smoking cessation, on cancer survivors. The results of this analysis did not
favor any one type of exercise program or setting and showed no difference
between shorter, less intensive programs and longer programs that were more
intensive.
"Regular physical activity is important for both lowering the risk
for and managing multiple diseases, including some cancers," commented
NCI Director Dr. Andrew von Eschenbach. "The more we understand about how to
help people start and maintain exercise programs, the more we can help cancer
survivors combat some of the early and late effects of cancer and its
treatment." The entire report is available at
http://cancercontrol.cancer.gov/d4d/evidence_report.html.
Dr. Anita Roberts Wins 2005 FASEB Excellence in Science
Award
Dr. Anita Roberts, principal investigator and former chief of the Laboratory of
Cell Regulation and Carcinogenesis, has won the Excellence in Science Award
from the Federation of American Societies for Experimental Biology (FASEB) for
2005. Sponsored by Eli Lilly and Company, this award recognizes outstanding
achievement by women in biological sciences whose research has contributed
significantly to further understanding of a particular discipline. In addition
to presenting the award lecture at the Experimental Biology meeting in San
Diego in April, 2005, Dr. Roberts will receive a $10,000 unrestricted research
grant, funded by Eli Lilly and Company.
EGRP Holds Leadership Conference for Epidemiologists
NCI's extramural research program in epidemiology, the Epidemiology and
Genetics Research Program (EGRP) recently held its first annual Epidemiology
Leadership Workshop to identify barriers and gaps in cancer epidemiology and
advance solutions to the study of tobacco, diet/energy balance, and genes. EGRP
is part of NCI's Division of Cancer Control and Population Sciences (DCCPS) and
manages a portfolio of 500 cancer epidemiology research grants totaling $200
million per year.
Dr. Catherine DeAngelis, editor-in-chief of the Journal of the
American Medical Association, gave the keynote address on the importance of
epidemiologic studies to public health. Other presentations were given by Dr.
Laurence Kolonel, Cancer Research Center of Hawaii, University of Hawaii, on
diet, genes, and cancer; Dr. Neil Caporaso, NCI's Division of Cancer
Epidemiology and Genetics (DCEG), on tobacco, genes, and cancer; Dr. Stephen
Chanock, DCEG and CCR, on genetics in epidemiology; Dr. Michael Thun, American
Cancer Society, on cohort consortia; and Dr. Patricia Hartge, DCEG, on
case-control consortia. Also speaking were Dr. Graham Colditz, Brigham and
Women's Hospital, Harvard University; Dr. Margaret Spitz, University of Texas
M.D. Anderson Cancer Center; and Drs. Robert Croyle, Jon Kerner, and Edward
Trapido, DCCPS.
As a result of the workshop, four research working groups based
on the breakout sessions' work will be formed: Diet/Energy Balance Epidemiology
Research, Haplotypes versus Genotypes, Epidemiology of Rare Cancers, and
Susceptibility to Tobacco Carcinogenesis. Extramural and intramural scientists
will collaborate in the groups to generate new scientific ideas and
hypotheses.
Participant presentations and more information about the workshop
will be made available on the EGRP Web site at epi.grants.cancer.gov.
|